Teaser Image JMCP Cover Image Teaser Text A summary of an ICER cost-effectiveness analysis published in JMCP found that despite incremental clinical benefits, biologics used to treat asthma have low long-term value for money. Tags (Topics): Value in Health Care URL https://www.jmcp.org/doi/abs/10.18553/jmcp.2019.25.5.510 Primary Taxonomy Tag Value-Based Care
